S&P 500   3,853.07 (+0.03%)
DOW   31,176.01 (-0.04%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
S&P 500   3,853.07 (+0.03%)
DOW   31,176.01 (-0.04%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
S&P 500   3,853.07 (+0.03%)
DOW   31,176.01 (-0.04%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
S&P 500   3,853.07 (+0.03%)
DOW   31,176.01 (-0.04%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
Log in
NASDAQ:ICUI

ICU Medical Stock Forecast, Price & News

$217.66
-0.11 (-0.05 %)
(As of 01/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$215.41
Now: $217.66
$220.38
50-Day Range
$188.97
MA: $209.37
$222.54
52-Week Range
$158.01
Now: $217.66
$236.51
Volume124,493 shs
Average Volume170,407 shs
Market Capitalization$4.57 billion
P/E Ratio57.58
Dividend YieldN/A
Beta0.72
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in vascular therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation, such as sodium chloride irrigation, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. Further, it provides ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms, as well as related professional services. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
ICU Medical logo

MarketRank

Overall MarketRank

1.26 out of 5 stars

Medical Sector

753rd out of 1,926 stocks

Surgical & Medical Instruments Industry

77th out of 169 stocks

Analyst Opinion: 1.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ICUI
CUSIP44930G10
Phone949-366-2183
Employees8,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.27 billion
Cash Flow$11.57 per share
Book Value$66.62 per share

Profitability

Net Income$101.04 million

Miscellaneous

Market Cap$4.57 billion
Next Earnings Date2/25/2021 (Estimated)
OptionableOptionable
$217.66
-0.11 (-0.05 %)
(As of 01/21/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ICUI News and Ratings via Email

Sign-up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











ICU Medical (NASDAQ:ICUI) Frequently Asked Questions

How has ICU Medical's stock been impacted by COVID-19 (Coronavirus)?

ICU Medical's stock was trading at $180.56 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ICUI shares have increased by 20.5% and is now trading at $217.66.
View which stocks have been most impacted by COVID-19
.

Is ICU Medical a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ICU Medical stock.
View analyst ratings for ICU Medical
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than ICU Medical?

Wall Street analysts have given ICU Medical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but ICU Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Doug Parker's approval rating as ICU Medical's CEO?

1,448 employees have rated ICU Medical CEO Doug Parker on Glassdoor.com. Doug Parker has an approval rating of 60% among ICU Medical's employees. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

When is ICU Medical's next earnings date?

ICU Medical is scheduled to release its next quarterly earnings announcement on Thursday, February 25th 2021.
View our earnings forecast for ICU Medical
.

How were ICU Medical's earnings last quarter?

ICU Medical, Inc. (NASDAQ:ICUI) posted its quarterly earnings data on Thursday, November, 5th. The medical instruments supplier reported $1.90 earnings per share for the quarter, topping analysts' consensus estimates of $1.31 by $0.59. The medical instruments supplier had revenue of $318.60 million for the quarter, compared to the consensus estimate of $291.37 million. ICU Medical had a return on equity of 9.73% and a net margin of 6.43%. The company's revenue for the quarter was up 3.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.65 earnings per share.
View ICU Medical's earnings history
.

What guidance has ICU Medical issued on next quarter's earnings?

ICU Medical updated its FY 2020 After-Hours earnings guidance on Thursday, November, 5th. The company provided EPS guidance of 6.65-7.00 for the period, compared to the Thomson Reuters consensus estimate of $6.40.

What price target have analysts set for ICUI?

3 brokers have issued 12 month price targets for ICU Medical's shares. Their forecasts range from $210.00 to $236.00. On average, they anticipate ICU Medical's stock price to reach $223.00 in the next year. This suggests a possible upside of 2.5% from the stock's current price.
View analysts' price targets for ICU Medical
or view Wall Street analyst' top-rated stocks.

Who are some of ICU Medical's key competitors?

What other stocks do shareholders of ICU Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton, Dickinson and (BDX), BlackRock (BLK), NVIDIA (NVDA), Alibaba Group (BABA), CA (CA), UnitedHealth Group (UNH), The Boeing (BA), Micron Technology (MU), Lockheed Martin (LMT) and ServiceNow (NOW).

Who are ICU Medical's key executives?

ICU Medical's management team includes the following people:
  • Mr. Vivek Jain, CEO & Chairman (Age 49, Pay $824.88k)
  • Mr. Christian B. Voigtlander, Chief Operating Officer (Age 53, Pay $495.38k)
  • Ms. Virginia Ruth Sanzone, Corp. VP, Gen. Counsel & Sec. (Age 45, Pay $402.38k)
  • Mr. Daniel Woolson, Corp. VP & GM of Infusion Systems (Age 44, Pay $402.38k)
  • Mr. Brian Michael Bonnell, CFO & Treasurer (Age 47)
  • Mr. Kevin J. McGrody, Chief Accounting Officer
  • Mr. Steven C. Riggs, Exec. Officer of Special Project Opertions (Age 62)

What is ICU Medical's stock symbol?

ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."

Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by a variety of retail and institutional investors. Top institutional investors include Boston Trust Walden Corp (0.60%), Scout Investments Inc. (0.23%), AMI Asset Management Corp (0.17%), Kirr Marbach & Co. LLC IN (0.11%), DNB Asset Management AS (0.07%) and Private Trust Co. NA (0.03%). Company insiders that own ICU Medical stock include Christian B Voigtlander, Elisha W Finney, George A Lopez, Kevin J Mcgrody, Robert S Swinney, Scott E Lamb, Virginia Ruth Sanzone and Vivek Jain.
View institutional ownership trends for ICU Medical
.

Which institutional investors are selling ICU Medical stock?

ICUI stock was sold by a variety of institutional investors in the last quarter, including AMI Asset Management Corp, Pacer Advisors Inc., Boston Trust Walden Corp, Crossmark Global Holdings Inc., Kirr Marbach & Co. LLC IN, State of Alaska Department of Revenue, and Raymond James Trust N.A.. Company insiders that have sold ICU Medical company stock in the last year include Elisha W Finney, George A Lopez, Robert S Swinney, Virginia Ruth Sanzone, and Vivek Jain.
View insider buying and selling activity for ICU Medical
or view top insider-selling stocks.

Which institutional investors are buying ICU Medical stock?

ICUI stock was purchased by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Scout Investments Inc., Private Trust Co. NA, and Exchange Traded Concepts LLC.
View insider buying and selling activity for ICU Medical
or or view top insider-buying stocks.

How do I buy shares of ICU Medical?

Shares of ICUI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ICU Medical's stock price today?

One share of ICUI stock can currently be purchased for approximately $217.66.

How big of a company is ICU Medical?

ICU Medical has a market capitalization of $4.57 billion and generates $1.27 billion in revenue each year. The medical instruments supplier earns $101.04 million in net income (profit) each year or $7.36 on an earnings per share basis. ICU Medical employs 8,000 workers across the globe.

What is ICU Medical's official website?

The official website for ICU Medical is www.icumed.com.

How can I contact ICU Medical?

ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The medical instruments supplier can be reached via phone at 949-366-2183 or via email at [email protected]

This page was last updated on 1/21/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.